Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Mechanisms of Retrovirus-induced Cancers

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Erythrocyte Fragility in Progressive Multiple Sclerosis.

European journal of neurology·2026

Same author

Intra-pol proviral open region of HTLV-1 controls the transcription from both long terminal repeats.

Retrovirology·2025

Same author

Penetrant PKCβ mutation in ATLL displays a mixed gain-of-function.

The Biochemical journal·2025

Same author

The impact of HTLV-1 expression on the 3D structure and expression of host chromatin.

PLoS pathogens·2024

Same author

The transcriptome of HTLV-1-infected primary cells following reactivation reveals changes to host gene expression central to the proviral life cycle.

PLoS pathogens·2023

Same author

HTLV-1 persistence and the oncogenesis of adult T-cell leukemia/lymphoma.

Blood·2023

Search research articles

Related Experiment Video

Updated: Feb 18, 2026

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

Published on: August 31, 2014

Human T Cell Leukemia Virus Type 1: Persistence and Pathogenesis.

Charles R M Bangham¹

¹Division of Infectious Diseases, Faculty of Medicine, Imperial College, London W2 1PG, United Kingdom;

Annual Review of Immunology

|November 18, 2017

Summary

Human T cell leukemia virus type 1 (HTLV-1) persists in the body and causes serious diseases in a small percentage of infected individuals. Current treatments are ineffective against HTLV-1-associated conditions.

Keywords:

ATL HAM/TSP HTLV-1 latency retrovirus

More Related Videos

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing

Published on: October 16, 2018

Author Spotlight: Elucidating the Pathways of TFH Cell Differentiation in Acute LCMV Challenges

Author Spotlight: Elucidating the Pathways of TFH Cell Differentiation in Acute LCMV Challenges

Published on: April 26, 2024

Related Experiment Videos

Last Updated: Feb 18, 2026

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

Published on: August 31, 2014

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing

Published on: October 16, 2018

Author Spotlight: Elucidating the Pathways of TFH Cell Differentiation in Acute LCMV Challenges

Author Spotlight: Elucidating the Pathways of TFH Cell Differentiation in Acute LCMV Challenges

Published on: April 26, 2024

Area of Science:

Virology
Immunology
Infectious Diseases

Background:

Human T cell leukemia virus type 1 (HTLV-1) is the first identified exogenous human retrovirus.
Unlike HIV-1, HTLV-1 causes disease in only 5-10% of infected individuals, with prevalence varying by ethnicity.
Effective antiretroviral treatments exist for HIV-1, but not for HTLV-1-associated malignant or inflammatory diseases.

Purpose of the Study:

To review recent advances in understanding HTLV-1 persistence in vivo.
To elucidate the mechanisms underlying HTLV-1-induced diseases.

Main Methods:

Review of recent scientific literature on HTLV-1.
Analysis of mechanisms of viral persistence.
Examination of pathogenesis of HTLV-1-associated diseases.

Main Results:

Recent studies have shed light on how HTLV-1 establishes long-term infection within the host.
Key molecular and cellular mechanisms contributing to the development of HTLV-1-related diseases have been identified.
Understanding viral persistence is crucial for developing effective therapeutic strategies.

Conclusions:

HTLV-1 infection presents unique challenges due to its complex persistence mechanisms.
There is an urgent need for novel therapeutic approaches to manage HTLV-1-associated diseases.
Further research into viral persistence and pathogenesis is essential for future treatment development.